26th Oct 2021

AstraZeneca must deliver 50m doses by September or face fines

  • If the UK-based pharmaceutical giant does not comply with the timetable set by the court, there will be a €10 fine per dose not delivered (Photo: Cheshire East Council)

A Brussels court on Friday (18 June) ordered AstraZeneca to deliver 50 million doses of Covid-19 vaccines to EU member states by September, in a legal case brought by the European Commission - with both sides claiming victory.

AstraZeneca is now expected to supply 15 million doses by 26 July, 20 million doses by 23 August, and 15 million doses by 27 September.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Responding to the ruling, the company said it would "substantially exceed" these deliveries by the end of June.

However, the commission lawyers had asked for 90 million extra vaccines to be delivered by the end of June.

The EU Commission has refused to clarify the number of doses delivered to the EU so far.

However, AstraZeneca previously announced it aims to ship some 70 million doses by the end of June, in addition to the 30 million already delivered in the first quarter of 2021.

"To date, the company has supplied more than 70 million doses to the European Union and will substantially exceed 80.2 million doses by the end of June," said UK-based AstraZeneca, in a statement.

Under the EU Commission's contract with AstraZeneca, the company was supposed to deliver a total of 300 million doses to EU member states for the period between December and the end of June.

But manufacturing problems slowed down production, causing shortfalls and triggering a row that ended up in another, ongoing, legal battle.

'Breach of contractual obligations'

Friday's ruling shows that AstraZeneca committed a breach of its contractual obligations with the EU since the company should have deployed all its "best efforts" using all its available factories, including British production sites, to deliver the number of vaccines agreed timely.

"Oxford BioMedica should be used and must be used to catch up with its [AstraZeneca's] contractual obligations," an EU official said.

The judge's decision also adds that the EU was not informed of an "exclusivity deal" between the UK government and the British-Swedish pharmaceutical firm.

Meanwhile, both sides have claimed a victory.

"The judgment also acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay," AstraZeneca also said.

"AstraZeneca now looks forward to a renewed collaboration with the European Commission to help combat the pandemic in Europe," it adds.

EU officials, for their part, told reporters that "the judgement is entirely satisfying".

"This decision confirms the position of the commission: AstraZeneca did not live up to the commitments it made in the contract," EU Commission president Ursula von der Leyen said.

If the pharmaceutical company does not comply with this timetable, there will be a €10 fine per dose not delivered - with a maximum of €500m in penalties.

EU takes AstraZeneca to court for 'breaching contract'

The European Union has launched legal action against the pharmaceutical multinational AstraZeneca for failing to meet its contractual obligations for the supply of Covid-19 vaccines, and for lacking a "reliable strategy" to ensure timely deliveries.

EU mulls legal action against AstraZeneca over shortfalls

The European Commission said on Thursday it has not yet decided whether to take legal action against AstraZeneca for failing to meet its contractual obligations - but repeated that all options are still on the table.

Baltic states lead Covid surge across east Europe

The surge of Covid-19 infections in eastern EU member countries, particularly the Baltic states, is putting health systems under increasing pressure, prompting governments to reimpose restrictive measures.

EU exported over one billion vaccines so far

The EU has exported more than one billion doses of Covid-19 vaccines this year, and announced it will donate 500 million extra doses to poorer countries in the coming months.

News in Brief

  1. Timmermans cancels Moscow visit ahead of COP26
  2. Report: EU to open new mission in Kabul
  3. Bulgaria and Romania run out of beds for Covid-patients
  4. Afghanistan 'on brink of collapse', Sweden warns
  5. Far-right vigilantes stopped on Polish-German border
  6. Croatian right-wingers seek euro referendum
  7. Orbán accuses EU and US of election meddling
  8. Militants free international observers in Russia-occupied Ukraine

EU Commission tightlipped on Hungary recovery-plan decision

Among the criteria needed for EU pandemic recovery funds is for member states to propose arrangements "expected to prevent, detect and correct corruption, fraud, and conflicts of interests when using the funds provided."

Stakeholders' Highlights

  1. Nordic Council of MinistersNew report reveals bad environmental habits
  2. Nordic Council of MinistersImproving the integration of young refugees
  3. Nordic Council of MinistersNATO Secretary General guest at the Session of the Nordic Council
  4. Nordic Council of MinistersCan you love whoever you want in care homes?
  5. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  6. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals

Latest News

  1. Erdoğan orders out US and EU ambassadors
  2. EU banks play 'major role' in deforestation, report finds
  3. NGOs reveal 71 'revolving-door' cases at fossil-fuel giants
  4. Energy and gender in EU focus This WEEK
  5. Nato invite sees Nordic states stepping up security cooperation
  6. Lessons for the EU in Sahel, from Afghanistan
  7. EU states want more Belarus sanctions
  8. Gas price spike exposes rift at EU summit

Join EUobserver

Support quality EU news

Join us